Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sumi Indo Kabel Tbk. (IKBI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Sumi Indo Kabel Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Sumi Indo Kabel Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sumi Indo Kabel Tbk. trades at Rp555 (market cap 673.2B, 454.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Sumi Indo Kabel Tbk. is far larger — about 4.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sumi Indo Kabel Tbk. is more actively traded (454.5K versus 62.5K). Which is the better fit depends on your goals.

IKBIOBAT
Market Cap
673.2B164.65B
Volume
454.5K62.5K
Lot
4.55K625
Turnover
255.14M15.03M
Average Price
561.37240.55
Value
255.14M15.03M
Indicative Equilibrium Price
555238
Indicative Equilibrium Volume
108100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IKBI
View details
OBAT
View details

About Sumi Indo Kabel Tbk.

The Company was established on July 23, 1981 with its Head Office and Factory located in Tangerang, West Java. The Company was listed in JSX and SSX in 1990. On 1994 the Company changed status of the Company to become Foreign Capital Investment (PMA), right after participation of Sumitomo Electric Industries, Ltd., Japan which is one of the biggest in the world in cable industry and PT Perdanamulia Ekasakti.

Read more on IKBI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT